Drug Profile
Research programme: monomethyl fumarate conjugates - V ClinBio
Alternative Names: VCB 101; VCB 102; VCB 103; VCB 104; VCB 105; VCB 106Latest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator V ClinBio
- Class Antipsoriatics; Drug conjugates
- Mechanism of Action NF E2 related factor 2 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Multiple sclerosis; Psoriasis
Most Recent Events
- 28 Mar 2022 No recent reports of development identified for preclinical development in Multiple-sclerosis in USA (IV)
- 28 Mar 2022 No recent reports of development identified for preclinical development in Multiple-sclerosis in USA (PO)
- 28 Mar 2022 No recent reports of development identified for preclinical development in Psoriasis in USA (IV)